Veteran investor and operating executive focused on growth-stage technology and fintech companies, with experience across corporate strategy, M&A and capital markets. Matthew Francis Dean is known for leading strategic investments, taking board seats and executing operational turnarounds at portfolio companies, combining deal experience with hands-on operating responsibilities. Holds graduate and undergraduate degrees with a finance and strategy orientation and maintains an active advisory and angel investing presence.
Veteran investor and operating executive focused on growth-stage technology and fintech companies, with experience across corporate strategy, M&A and capital markets. Matthew Francis Dean is known for leading strategic investments, taking board seats and executing operational turnarounds at portfolio companies, combining deal experience with hands-on operating responsibilities. Holds graduate and undergraduate degrees with a finance and strategy orientation and maintains an active advisory and angel investing presence.
Focuses on growth-stage technology and fintech opportunities where strategic capital and operator-led guidance accelerate scale. Prioritizes investments with clear product-market fit, recurring revenue models and defensible unit economics, then partners actively through board roles and hands-on operational support. Capital allocation favors equity in follow-on rounds to preserve upside while using disciplined valuation thresholds and milestone-driven tranche commitments. Time horizon is multi-year, targeting transformational growth and exit via strategic sale or IPO; risk managed through concentrated expertise, operational intervention and selective syndication.
Focuses on growth-stage technology and fintech opportunities where strategic capital and operator-led guidance accelerate scale. Prioritizes investments with clear product-market fit, recurring revenue models and defensible unit economics, then partners actively through board roles and hands-on operational support. Capital allocation favors equity in follow-on rounds to preserve upside while using disciplined valuation thresholds and milestone-driven tranche commitments. Time horizon is multi-year, targeting transformational growth and exit via strategic sale or IPO; risk managed through concentrated expertise, operational intervention and selective syndication.
| Trades 688 | Longs Won 403/688 58% | Profit Factor 3.18 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $903,120.49 |
| Average Win $207,482.09 | Best Trade (Jun 30) $20.3M | Sharpe Ratio -5.1 |
| Average Loss -$92,310.58 | Worst Trade (Aug 19) -$5.88M | Z-Score 3.9 (100%) |
| Commissions $0 | Avg. Trade Length 9m 2d | Expectancy $83,265.75 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.09% |
| Consecutive Losing Trades | 3,521 | 3,169 | 2,817 | 2,465 | 2,113 | 1,761 | 1,408 | 1,056 | 704 | 352 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 27,509 | $5.92M | $8.5M | - | $2.58M | 43.63% | -7.354% |
ABBV AbbVie Inc. | 1,635 | $295,948.9 | $410,286.9 | - | $114,338 | 38.63% | -2.513% |
ABT Abbott Laboratories | 675 | $81,556.78 | $71,347.5 | - | -$10,209.28 | -12.52% | +0.085% |
ACN Accenture plc Class A | 245 | $60,417 | $40,650.4 | - | -$19,766.6 | -32.72% | +1.611% |
ADBE Adobe Inc. | 15 | $5,803.2 | $3,756.15 | - | -$2,047.05 | -35.27% | +1.013% |
AEM Agnico Eagle Mines Limited | 750 | $126,295 | $108,952.5 | - | -$17,342.5 | -13.73% | -3.635% |
AER AerCap Holdings N.V. | 795 | $96,195 | $119,965.49 | - | $23,770.49 | 24.71% | -1.289% |
AG First Majestic Silver Corp | 4,700 | $57,704 | $70,641 | - | $12,937 | 22.42% | -4.207% |
AGI Alamos Gold Inc. | 3,300 | $115,004 | $91,839 | - | -$23,165 | -20.14% | -2.007% |
ALC Alcon Inc. | 400 | $29,762.67 | $27,576 | - | -$2,186.67 | -7.35% | -0.963% |
AMD Advanced Micro Devices, Inc. | 100 | $15,264.06 | $47,615 | - | $32,350.94 | 211.94% | -1.904% |
AMT American Tower Corporation | 1,058 | $230,220.8 | $183,414.88 | - | -$46,805.92 | -20.33% | -0.631% |
AMZN Amazon.com Inc | 25,400 | $5.58M | $6.9M | - | $1.32M | 23.59% | +15.321% |
APD Air Products and Chemicals, Inc. | 220 | $62,027.78 | $64,875.8 | - | $2,848.02 | 4.59% | -1.769% |
APH Amphenol Corporation | 468 | $29,583.7 | $37,603.8 | - | $8,020.1 | 27.11% | +0.551% |
AU AngloGold Ashanti plc | 500 | $35,165 | $39,660 | - | $4,495 | 12.78% | -3.656% |
AZN AstraZeneca PLC American Depositary Shares | 21,991 | $4.27M | $3.73M | - | -$542,399.76 | -12.69% | -0.992% |
BABA Alibaba Group Holding Limited SP ADR | 50 | $5,670.5 | $6,112.5 | - | $442 | 7.79% | +5.098% |
BAC Bank of America Corporation | 33,295 | $1.64M | $2.06M | - | $423,072.85 | 25.8% | +0.356% |
BDX Becton, Dickinson and Company | 561 | $82,548.91 | $92,912.82 | - | $10,363.91 | 12.55% | +0.103% |